All.Can International is pleased to announce that Pfizer has recently joined our organisation as a member.
Pfizer Inc. is a leading global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines and vaccines that improve lives. Headquartered in New York City, Pfizer has a legacy dating back to 1849 and operates in more than 125 countries. The company focuses on a wide range of therapeutic areas, including oncology, cardiology, immunology, rare diseases, and infectious diseases. Pfizer gained global recognition for its role in developing one of the first COVID-19 vaccines in partnership with BioNTech. With a strong emphasis on science, access, and equity, Pfizer continues to invest in research and innovation to tackle some of the world’s most pressing health challenges.
Pfizer’s participation in the All.Can initiative—and its contributions to advancing meaningful progress—play an important role in improving outcomes for people living with cancer and strengthening healthcare systems.